← All trials
NCT03789617
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 14, 2018
- Primary completion
- Sep 30, 2020
- Completion date
- Dec 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 28
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- EutilexLead sponsor
- The National Cancer CenterOverall official - principal investigator
- Catholic University of KoreaOverall official - principal investigator
- Sungkyunkwan UniversityOverall official - principal investigator
- Inje UniversityOverall official - principal investigator
- Pusan National UniversityOverall official - principal investigator
- Chonnam National UniversityOverall official - principal investigator
- Kyungpook UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.